RM

Rajendrakumar Makhanlal Gupta

Active Director Director DIN 01714805
DIN 01714805 First appointment Apr 1989 Primary industry Machinery and Equipment
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 2 historical roles
Total affiliations 5 Since Apr 1989
Shareholding value •••• Premium profile

About Rajendrakumar Makhanlal Gupta

Data last updated:

Rajendrakumar Makhanlal Gupta is a Director at Impact Labs Private Limited (since 1989), Director at Nikko Systems Private Limited (since 1996) and Designated Partner at Dove Pharma Llp (since 2012). The companies operate in Machinery and Equipment, Pharma and Industrial Manufacturing. The 3 current companies with reported revenue have a combined latest revenue of ₹69.80 Cr; the largest is Impact Labs Private Limited at ₹52.54 Cr (FY 2025). Earlier, Rajendrakumar Makhanlal Gupta was a Director at Nikko Korus Equipment & Technologies Private Limited (2011–2012) and Director at E14 Technologies Private Limited (2011–2019).

DIN 01714805
Primary Designation Director
Industry Machinery and Equipment
First Appointment 27 Apr 1989
Oldest Company Age 37 yrs
Largest company Impact Labs Private Limited · ₹52.54 Cr (FY 2025)
Combined revenue ₹69.80 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Impact Labs Private Limited U24200MH1989PTC051535
Director27 Apr 19891989₹52.54 Cr (FY 2025)Active
Nikko Systems Private Limited U28113MH1996PTC101633
Director06 Aug 19961996₹8.91 Cr (FY 2025)Active
Dove Pharma Llp AAA-9155
Designated Partner10 May 20122012₹8.35 Cr (FY 2021)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jul 20112010₹16,259 (FY 2025)Active
E14 Technologies Private Limited U74999MH2011PTC220923
Director12 Aug 20112011₹12.6 Lakh (FY 2023)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Impact Labs Private Limited
Nikko Systems Private Limited
Dove Pharma Llp
Nikko Korus Equipment & Technologies Private Limited
Premium access

Shareholding and investment profile for Rajendrakumar Makhanlal Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendrakumar Makhanlal Gupta

Rajendrakumar Makhanlal Gupta currently holds 3 directorships: Impact Labs Private Limited (Director, since 27 Apr 1989, revenue ₹52.54 Cr (FY 2025)); Nikko Systems Private Limited (Director, since 06 Aug 1996, revenue ₹8.91 Cr (FY 2025)); Dove Pharma Llp (Designated Partner, since 10 May 2012, revenue ₹8.35 Cr (FY 2021)).

Rajendrakumar Makhanlal Gupta was first appointed on 27 Apr 1989 as Director at Impact Labs Private Limited. The most recent appointment on record is 10 May 2012 at Dove Pharma Llp.

The 3 current companies of Rajendrakumar Makhanlal Gupta that report revenue have a combined latest revenue of ₹69.80 Cr: Impact Labs Private Limited ₹52.54 Cr (FY 2025); Nikko Systems Private Limited ₹8.91 Cr (FY 2025); Dove Pharma Llp ₹8.35 Cr (FY 2021).

Rajendrakumar Makhanlal Gupta held 2 earlier board appointments: Nikko Korus Equipment & Technologies Private Limited (Director, 18 Jul 2011 to 07 May 2012); E14 Technologies Private Limited (Director, 12 Aug 2011 to 25 Mar 2019).

The current boards of Rajendrakumar Makhanlal Gupta's companies include Pramesh Rajendrakumar Gupta (Impact Labs Private Limited), Sanjay Mukutlal Gupta (Impact Labs Private Limited), Jimmy Minocher Adajania (Nikko Systems Private Limited), Vispi Jimmy Adajania (Nikko Systems Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available